MicroRNA106a confers cisplatin resistance in nonsmall cell lung cancer A549 cells by targeting adenosine triphosphatasebinding cassette A1

Publisher： Spandidos Publications

E-ISSN： 1791-3004|11|1|625-632

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.11, Iss.1, 2015-01, pp. : 625-632

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

microRNA99a is downregulated and promotes proliferation, migration and invasion in nonsmall cell lung cancer A549 and H1299 cells

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1128-1134

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2639-2646

Spandidos Publications

Access to resources Recommend Favorite

Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 523-528

Spandidos Publications

Access to resources Recommend Favorite

microRNA106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells

By        

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 183-188

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathway

By        

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3854-3859

Spandidos Publications

Access to resources Recommend Favorite